2004
DOI: 10.1111/j.1651-2227.2004.tb02944.x
|View full text |Cite
|
Sign up to set email alerts
|

Intractable congenital chylous ascites

Abstract: A male newborn presented with congenital chylous ascites, the treatment of which is difficult and complicated due to persistent loss of chyle. The primary therapeutic goal is to reduce the lymph flow and to allow the leakage to heal naturally. Usually, conservative management—enteric rest with total parental feeding or an enteral diet with medium‐chain triglycerides—can achieve this. A new treatment option is the use of octeotride, a somatostatin analogue. Both therapies failed in our patient, and surgical lig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…[3,7] Although some investigators have reported the successful use of octreotide in congenital CA, [4,8] others have demonstrated octreotide to be inadequate even at a maximum intravenous (IV) dose of 10 μg/kg/h. [9] A study conducted by Huang et al [4] used octreotide at 1.5 μg/ kg/h IV for 10 days, whereas other studies used octreotide at an initial dose of 0.5 μg/kg/h IV, gradually titrated to 2 μg/ kg/h for nine days. [8] In our case, octreotide was started at 3 μg/kg/h and increased to 8 μg/kg/h following unresponsiveness to lower doses.…”
Section: Discussionmentioning
confidence: 99%
“…[3,7] Although some investigators have reported the successful use of octreotide in congenital CA, [4,8] others have demonstrated octreotide to be inadequate even at a maximum intravenous (IV) dose of 10 μg/kg/h. [9] A study conducted by Huang et al [4] used octreotide at 1.5 μg/ kg/h IV for 10 days, whereas other studies used octreotide at an initial dose of 0.5 μg/kg/h IV, gradually titrated to 2 μg/ kg/h for nine days. [8] In our case, octreotide was started at 3 μg/kg/h and increased to 8 μg/kg/h following unresponsiveness to lower doses.…”
Section: Discussionmentioning
confidence: 99%
“…Infant formulas containing a higher proportion of medium chain triglycerides (which are directly absorbed into the portal system bypassing the lymphatics) or enteric rest with total parenteral nutrition support are the initial measures utilized. One to 2 months of conservative therapy has been suggested [4]. The response to conservative therapy has been variable [2] and controversy exists regarding the duration of this treatment modality before considering surgical intervention.…”
Section: Discussionmentioning
confidence: 99%